DWDan Witmer

Dan Witmer

*This is an algorithmically generated author record based on publicly available information.

Dan Witmer has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Implementation of Robotic-Assisted Procedure for Total Hip Arthroplasty Is Not Economical in a High-Volume Orthopaedic Facility

    by Andrea T. Kwaczala, Sara E. Strecker, Matthew J. Solomito, Caitlin McCracken, Robert Carangelo, Daniel Witmer

    Background: Advances in elective primary total hip arthroplasty (THA) have led to the use of robotic assistance and computer navigation during surgery; recent reports have demonstrated substantial benefits of this technology. However, few studies have made a head-to-head comparison of technology with a specific focus on patient-reported outcomes (PROs) when preoperative patient profiles are well controlled. Therefore, the purpose of this study was to compare outcomes among patients who underwent conventional, robotic-assisted, and computer-navigated procedures. Methods: This retrospective study included patients aged 25 to 89 years who underwent THAs between January 2020 and May 2025. Patients were matched on age, body mass index (BMI), Charlson Comorbidity Index (CCI), and preoperative Hip Disability and Osteoarthritis Outcome Score for Joint Replacement and were assigned to study groups based on the technology used: (1) conventional, (2) robotic-assisted, and (3) computer-navigated. Postoperative recovery metrics between groups were compared up to 1 year from the surgery. Results: A total of 3799 patients were included: 2582 (68%) in the conventional group, 389 (10%) in the robotic-assisted group, and 828 (22%) in the computer-navigated group. PROs improved with no differences between groups by 12 months but showed slightly slower recovery in computer-navigated cases. Complication rates (return to operating room and hospital readmittance) were similar in all groups. Both robotic-assisted surgery and computer-navigated procedures cost around $1000 more than the conventional procedure, with robotic-assisted procedures taking 3 minutes longer than conventional procedures ( P < 0.05). Conclusion: Despite added cost, the technology-assisted procedures did not offer substantial improvements to surgical outcomes when used in primary THAs in a high-volume orthopaedic hospital. When controlled by matching demographics, comorbidities, and PROs, the technology-supported THA patients had no clinically relevant differences in postoperative outcomes and had higher hospital utilization compared with the conventional group.

  • Open Access

    Comparison of Outcomes Between Modular Dual Mobility and Conventional Hip Implants in Primary, Elective Total Hip Arthroplasty

    by Robert James Carangelo, Sara Elaine Strecker, Matthew J. Solomito, Dan Witmer

    Introduction: Modular dual mobility designs (MDM) are designed to reduce the risk of postoperative dislocations following primary total hip arthroplasty (THA). This study investigated both the usage and outcomes (ie, patient-reported outcomes and complications) associated with MDM hips compared with conventional implant designs. Methods: Patients who underwent a THA at a single, tertiary, orthopaedic specialty hospital between January 2019 and June 2022 were included. Primary outcomes of interest were compared between MDM and conventional hip designs and included complication rates, dislocation rates, clinical outcomes, and the hip disability and osteoarthritis outcome score for joint replacement (HOOS, JR). Results: A total of 2869 patients (88% conventional THA) were included in this study. Modular dual mobility hip utilization increased 117% during the study period. Patients in the MDM group were often older females (P < 0.001) with concomitant lumbar pathology (P = 0.034). None of the MDM hips dislocated in the first 30 days post THA compared with 0.4% of the conventional hips. Despite markedly lower hip disability and osteoarthritis outcome score for joint replacement scores in the MDM group, the number of patients reaching the minimally clinically important difference was similar (P = 0.915). Conclusion: MDM patients experience lower rates of dislocation compared with those receiving conventional implants. Despite worse clinical outcomes and increased all-cause emergency department utilization in the MDM group, multivariate regression suggests that these outcomes were associated with the implant being used in an older, sicker population instead of the implant itself. The results suggest similar overall outcomes and a lower dislocation rate for patients who received an MDM hip.


  • Open Access

    Preoperative Patient-Reported Outcomes Predict Candidacy for Outpatient Total Knee Arthroplasty

    by Bhavana Gunda, Sara Strecker, Robert James Magaldi, Donald A. Allen, Dan Witmer

    Background: The incidence of total knee arthroplasty (TKA), an effective orthopaedic procedure for end-stage osteoarthritis, is increasing substantially. The shift toward performing this procedure in the outpatient setting necessitates precise patient selection criteria to ensure optimal postoperative outcomes. This study examines the predictive value of preoperative patient-reported outcome measures (PROMs), including the Brief Resilience Scale (BRS), in determining candidacy for outpatient TKA. Methods: A retrospective analysis of 2,167 patients undergoing elective primary, unilateral TKA from May 2020 to June 2023 was conducted. Preoperative PROMs, including Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS, JR), Patient-Reported Outcomes Measurement Information System (PROMIS)-10, Risk Assessment and Prediction Tool (RAPT), and BRS, were collected. Patients were stratified into three groups by BRS score: low (BRS score < 3), average (BRS score ≥ 3 and < 4.3), and high (BRS score ≥ 4.3) resilience. Length of stay (LOS), discharge disposition, and complications were assessed postoperatively. Logistic regression and receiver operative characteristic (ROC) curve analyses were used to assess the predictive validity of PROMs for discharge to a skilled nursing facility (SNF) in conjunction with extended LOS. Results: Patients with low resilience (BRS score < 3) were found to have a significantly higher likelihood of discharge to a SNF and extended LOS compared with the other two groups (11.5% vs. 1.6%, P < 0.001). Logistic regression demonstrated that BRS, RAPT, and PROMIS-10 scores were also notable predictors, with a combined model predicting an extended LOS and discharge to SNF with 82.4% sensitivity and 79.9% specificity. Conclusions: Preoperative PROMs such as BRS can serve as a valuable tool in predicting the failure of outpatient TKA. Incorporating preoperative PROMs into presurgical decision making can enhance patient selection for ambulatory procedures and improve surgical outcomes. Additional prospective studies are warranted to validate these findings within other elective surgical populations and to determine how to best modify resilience.

  • Open Access

    The Effect of the Design of Polyethylene Inserts in Total Knee Arthroplasty on Patient Reported Outcomes

    by Bhavana Gunda, Leah Goldberg, Angie Alban, Sara Strecker, Caitlin McCracken, Robert James Carangelo, Dan Witmer

    Introduction: Several types of polyethylene liners have been developed to address the specific needs of patients' anatomy within total knee arthroplasty (TKA). In modern TKA, the posterior-stabilized (PS) and the cruciate-retaining (CR) designs are the most common, with the medial congruent (MC) design becoming more popular. The MC total knee arthroplasty has a posterior dwell point allowing for more flexion. The purpose of this study was to determine differences in patient-reported outcomes (PROMs) or postoperative outcomes between these three TKAs. Methods: Patients who underwent a primary, elective, unilateral TKA between June 2021 and July 2023 were identified. Demographics and perioperative and postoperative outcomes were extracted from the medical record. PROMs from 624 patients were obtained through a digital engagement platform. A P value ≤0.05 was considered statistically significant. Results: Patients were subdivided into three groups; 111 PS-TKA, 278 CR-TKA, and 235 MC-TKAs. Most implants were Zimmer (71.5%) and were cemented (92.9%). Patients in the CR group were predominantly male (P = 0.003) and had a lower body mass index (P < 0.001). No differences were seen in Knee Injury and Osteoarthritis Outcome Score for Joint Replacement scores at any time point (preoperative: P = 0.073; 12 weeks: P = 0.144; 6 months: P = 0.666; 1 year: P = 0.622). A similar percentage of patients met the minimal clinically important difference (P = 0.480), and Forgotten Joint Scores were equivalent (P = 0.930). Patient physical therapy parameters (Timed Up and Go test [P = 0.779] and ambulation distance [P = 0.103]), inpatient pain levels (at rest: P = 0.101, with activity: P = 0.052), or morphine milligram equivalents dosed (P = 0.608) were comparable. No differences were seen in 30-day complications. Conclusion: This study fails to demonstrate a difference in PROMs, functional parameters, or complications between the PS-TKAs, CR-TKAs, and MC-TKAs. All three constructs perform similarly in the immediate postoperative period. Because equivalent outcomes occur with each polyethylene, implant choice should be left to physician preference.


  • Open Access

    The Influence of Multiple Modifiable Risk Factors on 30-day Readmissions and 90-day Major Complications After a Total Hip and Knee Arthroplasty: An Analysis of a Large Claims Database

    by Lucas M. Luong, Regina O. Kostyun, Daniel K. Witmer, John C. Grady-Benson

    Background: Preoperative optimization of modifiable risk factors (MRFs) for arthroplasty patients is a critical aspect of predicting and improving postoperative outcomes. This study evaluates the correlation between seven MRFs and postoperative adverse outcomes after total hip arthroplasty (THA) and total knee arthroplasty (TKA). Methods: A retrospective review of primary TKA and THA were identified from a large medical claims database. Patients were categorized based on the number of MRF diagnoses present before surgery (anemia, malnutrition, obesity, opioid abuse/dependence, mental illness, type 2 diabetes mellitus, and tobacco use), from zero to seven. Adverse outcomes evaluated were surgical site infections (SSIs), venous thromboembolic events (VTEs), and readmissions. Results: Of the patient records queried (THA = 303,857; TKA = 692,157), two or more MRFs were identified in 41% of THA patients and 47% of TKA patients. Patients with two or more MRFs were at an increased odds of developing an SSI, and patients with three or more MRFs had increase odds of having a 30-day hospital readmission. Conclusions: This study adds to the compendium of literature, which promotes preoperative optimization of MRFs in arthroplasty patients to decrease the risks of 90-day postoperative complications.


  • Open Access

    Glucagon-Like Peptide-1 Agonists in Total Hip Arthroplasty: Complications, Readmissions, and Patient-Reported Outcomes

    by Robert James Magaldi, Sara Elaine Strecker, Dan Witmer

    Background: Obesity and diabetes, although increasingly common among the general population, are critical and modifiable preoperative medical comorbidities that should be managed appropriately before elective total hip arthroplasty. Glucagon-like peptide-1 (GLP-1) agonists represent a novel treatment option for orthopaedic surgeons in addressing both weight loss and diabetic control in the preoperative setting. As their popularity continues to increase, it is important to understand the implications, safety, and outcomes associated with GLP-1 agonist use among patients undergoing elective total joint arthroplasty. Methods: A retrospective matched cohort analysis was conducted on all THA performed a high-volume orthopaedic hospital between June 2016 and December 2022. A total of 66 patients taking GLP-1 agonists were identified and matched in a 1:2 ratio by age, sex, and body mass index. Length of stay, inpatient complications, emergency department (ED) visits, readmissions, and Hip Osteoarthritis Outcome Score for Joint Replacement outcome scores were compared between the two groups using chi-squared tests and Student t test. Results: The GLP-1 cohort experienced a markedly higher rate of inpatient postoperative nausea and vomiting (18.2% vs. 6.0%, P = 0.011). Although more patient's taking GLP-1 agonists returned to the ED for nausea and vomiting among the GLP-1 cohort, no notable differences in ED volume were found between the two groups. Furthermore, no differences were reported in race, ethnicity, laterally, length of stay, or readmissions between the two cohorts. Conclusion: Despite the elevated risk of early postoperative nausea and vomiting among total hip arthroplasty patients taking GLP-1 agonists, their use was not associated with any notable differences in the length of stay, readmission rates, or other complications, including urinary retention and venous thromboembolism. Future studies should assess the appropriate window to stop GLP-1 agonists preoperatively and to investigate complications and outcomes associated with the different drugs and their dosages.